Clinical Trial Update: SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients [NA]

View source ↗

Summary

A completed clinical trial comparing sodium zirconium cyclosilicate (SZC) with sodium polystyrene sulfonate (SPS) for treatment of hyperkalemia in hemodialysis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia

Drugs mentioned

• SPS (sodium polystyrene sulfonate)
• SZC (sodium zirconium cyclosilate)

Snippet

Sponsor: Alexandria University | Conditions: Hyperkalemia | NA | Status: COMPLETED